Kindly MD, Inc. announced that on May 24, 2024, three new independent directors were appointed as members of the Company?s Board of Directors (the ?Board?). Amy Powell, Christian Robinson, and Gary Seelhorst were each appointed to the Board and each new independent director entered into an independent director agreement with the Company. Amy Powell, MD, FACP, FAMSSM, age 50, is currently a Professor (Clinical) in the Department of Orthopaedics at the University of Utah, where she has cared for intercollegiate athletes alongside active people across the lifespan for 20 years.

She graduated from the University of Washington with a Medical Doctorate (1999) and completed fellowship training in sports medicine (internal medicine) at the Cleveland Clinic Foundation in 2003. Dr. Powell brings vital clinical and research acumen which is crucial to enhancing and validating KindlyMD?s pain management approaches, specifically given the blend of multimodal pain management methods the company uses. Her 20 years of experience in caring for athletes and active individuals aligns with the company?s mission to reduce opioid usage while successfully treating patients, utilizing both her practical and theoretical insights in pain management.

Her role in medical education can further bolster KindlyMD?s research, clinical protocols, and patient education strategies in creating evidence-based guidelines and therapies. Christian Robinson, CPA, age 55, is currently the Corporate Controller at Pave America. Prior to that he was the Chief Financial Officer of the Zion Pharmaceuticals, LLC and Intrepid Biosciences, LLC group of companies (2021 ?

2023). He Graduated with a BBA in Accounting in 1996 from the University of Texas at Arlington and has been a licensed CPA for over 25 years. Christian started his career by working as an auditor for Deloitte from 1996 until 1999 and then worked at Ernst & Young from 1999 to 2003.

After leaving public accounting, Christian has worked in variety of accounting and finance positions for companies in the transportation, nutraceuticals, nuclear waste and medical cannabis industries, including a small startup industrial hemp extraction company (2019 ? 2021) and as a self-employed financial consultant (2016 ? 2019).

Mr. Robinson worked for Energy Solutions, Inc. as the Corporate Controller and Chief Accounting Officer (1996 ? 2016) where he helped take the company public in 2007, ensured Sarbanes-Oxley (SOX) compliance, and managed all SEC financial reporting and compliance matters. Given KindlyMD?s diversified services and data management, the company Christian?s vast experience in managing finances, ensuring compliance (such as with SOX), and overseeing SEC reporting qualifies Christian to serve on its Board and is pivotal for financial stability and regulatory adherence.

His experience with startups, particularly in the medical cannabis industry, resonates with KindlyMD?s approach to alternative treatments and may offer valuable insights into both strategic financial planning and industry-specific nuances. Ensuring that KindlyMD adheres to financial regulations and maintains transparent communication with investors and stakeholders will be crucial, especially in light of the company?s collection and management of sensitive patient data and its varied revenue streams (subscription, fee-for-service, etc). Gary Seelhorst, MS, MBA, age 52, currently serves as Senior VP of National Compliance & Governmental Affairs at Justice Grown, since 2018.

His 25-year background in Pharmaceuticals and Healthcare brings scientific rigor to KindlyMD. Gary previously worked with Clinics and Surgery Centers with Imprimis/Harrow Health as a VP of Business Development during the company?s biggest growth phase (2013-2017). His experience also includes lengthy stints at both Eli Lilly as a medical writer (1996-1998) and Pfizer as a Manager of Clinical Development (1998- 2003) and as Director of Corporate Development (2003-2006) as well as several start-ups developing corporate and expansion strategies.

He has a BS/BA from UC San Diego in Biochemistry/Psychology (1994), an MS in Clinical Physiology from Indiana University (1993), and an MBA with an emphasis in finance from the University of Michigan (2004). Gary?s 25-year background in Pharmaceuticals and Healthcare is invaluable for navigating the pharmaceutical landscape, especially regarding non-opioid alternatives qualifies him to serve on its Board. His business development role during the growth phase at Imprimis/Harrow Health, and his MBA with a focus on finance, could be crucial in aiding KindlyMD to strategically navigate its expansion strategies and potentially increase its service portfolio or market share.

His varied roles in both clinical and corporate development offer a balanced perspective that is particularly useful in ensuring that KindlyMD?s clinical and corporate strategies are aligned, sustainable, and optimized for both patient outcomes and business growth. Each new independent director will be a member of the Company?s Audit Committee, Compensation Committee, and the Nominating and Corporate Governance Committee. Christian Robinson will serve as the Chair of the Company?s Audit Committee and Gary Seelhorst will serve as the Chair of the Company?s Compensation Committee and the Company?s Nominating and Corporate Governance Committee.